SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 6, 2000, Pages 241-250

A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma

(3) Huland, E a Heinzer, H a Huland, H a

a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; ANTIPYRETIC AGENT; ANTITUSSIVE AGENT; RECOMBINANT INTERLEUKIN 2; BIOLOGICAL RESPONSE MODIFIER; INTERLEUKIN 2; RECOMBINANT PROTEIN;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; COUGHING; DATA BASE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEVER; FLU LIKE SYNDROME; GERMANY; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; MULTIVARIATE ANALYSIS; NETHERLANDS; QUALITY OF LIFE; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG SCREENING; FACTUAL DATABASE; INHALATIONAL DRUG ADMINISTRATION; KIDNEY TUMOR; LIFE TABLE; LUNG TUMOR; MEDIASTINUM TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; PROSPECTIVE STUDY; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; AGED; ANOREXIA; BIOLOGICAL RESPONSE MODIFIERS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; COUGH; DATABASES, FACTUAL; DRUG EVALUATION; FEMALE; FEVER; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; KIDNEY NEOPLASMS; LIFE TABLES; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MULTICENTER STUDIES; NEPHRECTOMY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034355109 PISSN: 00155500 EISSN: 25337602 Source Type: Journal
DOI: None Document Type: Article

Times cited : (9)

References (47)

1
- 0029590213
- Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer
- (1995) J. Immunother. Emphasis Tumor Immunol. , vol.18 , pp. 188-195
- Angevin, E.¹ Valteau-Couanet, D.² Farace, F.³ Dietrich, P.Y.⁴ Lecesne, A.⁵ Triebel, F.⁶ Escudier, B.⁷

2
- 9044233642
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines
- ASCO
- (1996) J. Clin. Oncol. , vol.14 , pp. 671-679

3
- 0027952660
- Pharmacokinetics of intrapleural recombinant interleukin 2 in immunotherapy for malignant pleural effusion
- (1994) Cancer , vol.73 , pp. 308-313
- Astoul, P.¹ Bertault-Peres, P.² Durand, A.³ Catalin, J.⁴ Vignal, F.⁵ Boutin, C.⁶

4
- 0026329153
- The out-patient use of recombinant human interleukin-2 and interferon alfa-2b in advanced malignancies
- (1991) Eur. J. Cancer , vol.27
- Atzpodien, J.¹ Kirchner, H.²

5
- 0025397096
- Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: A phase II outpatient study
- (1990) Mol. Biother. , vol.2 , pp. 18-26
- Atzpodien, J.¹ Korfer, A.² Evers, P.³ Franks, C.R.⁴ Knuver-Hopf, J.⁵ Lopez-Hanninen, E.⁶ Fischer, M.⁷ Mohr, H.⁸ Dallman, I.⁹ Hadam, M.¹⁰

6
- 0025330178
- Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies
- (1990) Lancet , vol.335 , pp. 1509-1512
- Atzpodien, J.¹ Korfer, A.² Franks, C.R.³ Poliwoda, H.⁴ Kirchner, H.⁵

7
- 0027333287
- Subcutaneous recombinant interleukin-2 and α-interferon in patients with advanced renal cell carcinoma: Results of a multicenter phase II study
- (1993) Cancer Biother. , vol.8 , pp. 289-300
- Atzpodien, J.¹ Kirchner, H.² de Mulder, P.³ Bodenstein, H.⁴ Oliver, T.⁵ Palmer, P.A.⁶ Franks, C.R.⁷ Poliwoda, H.⁸

8
- 0027742554
- European studies of interleukin-2 in metastatic renal cell carcinoma
- (1993) Sem. Oncol. , vol.20
- Atzpodien, J.¹ Kirchner, H.² Hanninen, E.L.³ Korfer, A.⁴ Fenner, M.⁵ Menzel, T.⁶ Deckert, M.⁷ Franzke, A.⁸ Jonas, U.⁹ Poliwoda, H.¹⁰

9
- 0028809089
- Multi-institutional home-therapy trial of recombinant interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma
- (1995) J. Clin. Oncol. , vol.13 , pp. 497-501
- Atzpodien, J.¹ Lopez Hanninen, E.L.² Kirchner, H.³ Bodenstein, H.⁴ Pfreundschuh, M.⁵ Rebmann, U.⁶ Metzner, B.⁷ Illiger, H.J.⁸ Jakse, G.⁹ Niesel, T.¹⁰

10
- 0025326018
- Local and regional immunotherapy of cancer with interleukin 2
- (1990) J. Cancer Res. Clin. Oncol. , vol.116 , pp. 1-7
- Bubenik, J.¹

11
- 0020636607
- Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL-2)-containing preparations
- (1983) Cancer Immunol. Immunother. , vol.14 , pp. 205-206
- Bubenik, J.¹ Perlmann, P.² Indrova, M.³ Simova, J.⁴ Jandlova, T.⁵ Neuwirt, J.⁶

12
- 0027731232
- A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2
- (1993) Sem. Oncol. , vol.20
- Buter, J.¹ Sleijfer, D.T.² van der Graaf, T.A.³ de Vries, E.G.⁴ Willemse, P.H.⁵ Mulder, N.H.⁶

13
- 0030798858
- Effectiveness of very low doses of immunotherapy in advanced renal cell cancer
- (1997) Br. J. Cancer , vol.76 , pp. 541-544
- Buzio, C.¹ De Palma, G.² Passalacqua, R.³ Potenzoni, D.⁴ Ferrozzi, F.⁵ Cattabiani, M.A.⁶ Manenti, L.⁷ Borghetti, A.⁸

14
- 0024247135
- Prognostic factors for survival in patients with recurrent or metastatic renal-cell carcinoma
- (1988) Cancer Res. , vol.48 , pp. 7310-7313
- Elson, P.J.¹ Witte, R.S.² Trump, D.L.³

15
- 0002464927
- Therapy of lung metastases of malignant melanomas with inhaled interleukin-2
- (in German)
- (1997) Der Hautarzt , vol.12 , pp. 894-896
- Enk, A.H.¹ Nashan, D.² Knop, J.³

16
- 0027957085
- Immunotherapy with interleukin-2 (IL-2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL-2
- (1994) Eur. J. Cancer , vol.30 , pp. 1078-1083
- Escudier, B.¹ Farace, F.² Angevin, E.³ Charpentier, F.⁴ Nitenberg, G.⁵ Triebel, F.⁶ Hercend, T.⁷

17
- 0031431311
- Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: An analysis of 203 consecutively treated patients
- (1997) Cancer J. Sci. Am. , vol.3
- Figlin, R.¹ Gitlitz, B.² Franklin, J.³ Dorey, F.⁴ Moldawer, N.⁵ Rausch, J.⁶ deKernion, J.⁷ Belldegrun, A.⁸

18
- 0027096349
- IL-2 treatment for cancer: From biology to gene therapy
- (1992) Br. J. Cancer B , pp. 992-998
- Foa, R.¹ Guarinin, A.² Gansbacher, B.³

19
- 0023707073
- Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells
- (1988) Cancer Res. , vol.48 , pp. 5864-5870
- Gemlo, B.T.¹ Palladino, M.² Jaffe, H.S.³ Espevik, T.P.⁴ Rayner, A.A.⁵

20
- 0032703878
- Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy
- (1999) J. Clin. Oncol. , vol.17 , pp. 3612-3620
- Heinzer, H.¹ Mir, T.S.² Huland, E.³ Huland, H.⁴

21
- 0031935841
- Survival in renal cell carcinoma - A randomized evaluation of tamoxifen vs interleukin 2, α-interferon (leucocyte) and tamoxifen
- (1998) Br. J. Cancer , vol.77 , pp. 1311-1317
- Henriksson, R.¹ Nilsson, S.² Colleen, S.³ Wersall, P.⁴ Helsing, M.⁵ Zimmerman, R.⁶ Engman, K.⁷

22
- 0024452961
- Local continuous high-dose interleukin-2: A new therapeutic model for the treatment of advanced bladder carcinoma
- (1989) Cancer Res. , vol.49 , pp. 5469-5474
- Huland, E.¹ Huland, H.²

23
- 0026515571
- Interleukin-2 by inhalation: Local therapy for metastatic renal cell carcinoma
- (1992) J. Urol. , vol.147 , pp. 344-348
- Huland, E.¹ Huland, H.² Heinzer, H.³

24
- 0027979468
- Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: Effectiveness and toxicity of mainly local treatment
- (1994) J. Cancer Res. Clin. Oncol. , vol.120 , pp. 221-228
- Huland, E.¹ Heinzer, H.² Huland, H.³

25
- 0031415256
- Inhalatory interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: Six years of experience
- (1997) Cancer J. Sci. Am. , vol.3
- Huland, E.¹ Heinzer, H.² Mir, T.S.³ Huland, H.⁴

26
- 0033840128
- Overview of interleukin-2 inhalation therapy
- (2000) Cancer J. Sci. Am. , vol.6
- Huland, E.¹ Heinzer, H.² Huland, H.³ Yung, R.⁴

27
- 0026015202
- The immunotherapy of human cancer with interleukin-2: Present status and future directions
- (1991) Cancer Invest. , vol.9 , pp. 529-542
- Kolitz, J.E.¹ Mertelsmann, R.²

28
- 0025768477
- Randomized study of interleukin-2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancer
- (1991) Arch. Surg. , vol.126 , pp. 898-903
- Koretz, M.J.¹ Lawson, D.H.² York, M.³ Graham, S.D.⁴ Murray, D.R.⁵ Gillespie, T.M.⁶ Levitt, D.⁷ Sell, K.M.⁸

29
- 0031464658
- High-dose regimen of interleukin-2 and interferon-alpha in combination with lymphokine-activated killer cells in patients with metastatic renal cell cancer
- (1997) J. Immunother. , vol.20 , pp. 312-320
- Kruit, W.H.J.¹ Goey, S.H.² Lamers, C.H.J.³ Gratama, J.W.⁴ Visser, B.⁵ Schmitz, P.I.⁶ Eggermont, A.M.⁷ Bolhuis, R.L.⁸ Stoter, G.⁹

30
- 0029090362
- Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma
- (1995) Cancer , vol.76 , pp. 824-832
- Law, T.M.¹ Motzer, R.² Mazumdar, M.³ Sell, K.W.⁴ Walther, P.J.⁵ O Connell, M.⁶ Khan, A.⁷ Vlamis, V.⁸ Vogelzang, N.J.⁹ Bajorin, D.F.¹⁰

31
- 0024512021
- Cardiorespiratory effects of immunotherapy with interleukin-2
- (1989) J. Clin. Oncol. , vol.7 , pp. 7-20
- Lee, R.E.¹ Lotze, M.T.² Skibber, J.M.³ Tucker, E.⁴ Bonow, R.O.⁵ Ognibene, F.P.⁶ Carrasquillo, J.A.⁷ Shelhamer, J.H.⁸ Parrillo, J.E.⁹ Rosenberg, S.A.¹⁰

32
- 0026543749
- Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cell cancer patients resistant to interferon-alpha
- (1992) Eur. J. Cancer , vol.28 , pp. 92-96
- Lissoni, P.¹ Barni, S.² Ardizzosa, A.³ Crispino, S.⁴ Paolorossi, F.⁵ Archili, C.⁶ Vaghi, M.⁷ Tancini, G.⁸

33
- 0027880212
- A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinoma
- (1993) Tumori , vol.79 , pp. 397-400
- Lissoni, P.¹ Barni, S.² Ardizzoia, A.³ Andres, M.⁴ Scardino, E.⁵ Cardellini, P.⁶ Della Bitta, R.⁷ Tancini, G.⁸

34
- 0028147594
- Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinoma
- (1994) Oncology , vol.51 , pp. 59-62
- Lissoni, P.¹ Barni, S.² Ardizzoia, A.³ Crispino, S.⁴ Paolorossi, F.⁵ Andres, M.⁶ Scardino, E.⁷ Tancini, G.⁸

35
- 0028882879
- Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1
- (1995) Tumori , vol.81 , pp. 261-264
- Lissoni, P.¹ Barni, S.² Ardizzoia, A.³ Frigerio, F.⁴ Paolorossi, F.⁵ Cazzaniga, M.⁶ Tancini, G.⁷ Rocco, F.⁸ Aapro, M.⁹

36
- 8944234343
- Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: Toxicity, pharmacokinetics, and biological effects
- (1996) Clin. Cancer Res. , vol.2 , pp. 1115-1122
- Lorenz, J.¹ Wilhelm, K.² Kessler, M.³ Peschel, C.⁴ Schwulera, U.⁵ Lissner, R.⁶ Struff, W.G.⁷ Huland, E.⁸ Huber, C.⁹ Aulitzky, W.E.¹⁰

37
- 0029027251
- Combination therapy with interferon alfa-2a and interleukin-2 for the treatment of metastatic cancer
- (1995) J. Clin. Oncol. , vol.13 , pp. 1110-1112
- Marincola, F.¹ White, D.E.² Wise, A.P.³ Rosenberg, S.A.⁴

38
- 7144227930
- Recombinant human interleukin-2, recombinant human interferon alpha-2a, or both in metastatic renal cell carcinoma
- (1998) N. Engl. J. Med. , vol.338 , pp. 1272-1278
- Negrier, A.¹ Escudier, B.² Lasset, C.³ Douillard, J.Y.⁴ Savary, J.⁵ Chevreau, C.⁶ Ravaud, A.⁷ Mercatello, A.⁸ Peny, J.⁹ Mousseau, M.¹⁰ Philip, T.¹¹ Tursz, T.¹²

39
- 0027433629
- A comparison of 2 modes of administration of recombinant interleukin-2: Continuous intravenous infusion alone versus subcutaneous administration plus interferon alpha in patients with advanced renal cell carcinoma
- (1993) Cancer Biother. , vol.8 , pp. 123-136
- Palmer, P.A.¹ Atzpodien, J.² Philip, T.³ Negrier, S.⁴ Kirchner, H.⁵

40
- 0032901763
- Combination therapy of pulmonary metastasised gynaecological cancer with inhalative interleukin-2: Results of a feasability study
- (in German)
- (1999) Geburtsh. Frauenheilk. , vol.59 , pp. 157-162
- Petzoldt, B.¹ Prietl, G.² Kupka, M.³ Kohler, S.⁴ Krebs, D.⁵ Wagner, U.⁶

41
- 0028227443
- Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma
- (1994) Br. J. Cancer , vol.69 , pp. 1111-1114
- Ravaud, A.¹ Negrier, S.² Cany, L.³ Merrouche, Y.⁴ Le Guillou, M.⁵ Blay, J.Y.⁶ Clavel, M.⁷ GAston, R.⁸ Oskam, R.⁹ Philip, T.¹⁰

42
- 0001066433
- Inhalation of interleukin-2 as second-line treatment: Charite experience
- (Abstract)
- (1999) Anticancer Res. , vol.19 , pp. 2010-2011
- Roigas, J.¹

43
- 0026718336
- Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis
- (1992) J. Clin. Oncol. , vol.10 , pp. 1119-1123
- Sleijfer, D.T.¹ Janssen, R.A.J.² Buter, J.³ de Vries, E.G.⁴ Willemse, P.H.⁵ Mulder, N.H.⁶

44
- 0024996777
- Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity
- (1990) J. Clin. Oncol. , vol.8 , pp. 1618-1629
- Steis, R.G.¹ Urba, W.J.² VanderMolen, L.A.³ Bookman, M.A.⁴ Smith II, J.W.⁵ Clark, J.W.⁶ Miller, R.L.⁷ Crum, E.D.⁸ Beckner, S.K.⁹ McKnight, J.E.¹⁰

45
- 8944239882
- Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma
- (1996) Ann. Oncol. , pp. 525-528
- Tourani, J.M.¹ Lucas, V.² Mayeur, D.³ Dufour, B.⁴ DiPalma, M.⁵ Boaziz, C.⁶ Grise, P.⁷ Varette, C.⁸ Pavlovitch, J.M.⁹ Pujade-Lauraine, E.¹⁰ Larregain, D.¹¹ Ecstein, E.¹² Untereiner, M.¹³ Vuillemin, E.¹⁴ Merran, S.¹⁵ Andrieu, J.M.¹⁶

46
- 0028334189
- A combination of subcutaneous recombinant interleukin-2 and recombinant interferon-α in the treatment of advanced renal cell carcinoma or melanoma
- (1994) Eur. J. Cancer , vol.30 , pp. 530-532
- Vuoristo, M.¹ Jantunen, I.² Pyrhonen, S.³ Muhonen, T.⁴ Kellokumpu-Lehtinen, P.⁵

47
- 0025081439
- Subcutaneous recombinant interleukin 2 in a dose-escalating regimen in patients with metastatic renal cell adenocarcinoma
- (1990) Cancer Res. , vol.50 , pp. 6708-6715
- Whitehead, R.P.¹ Ward, D.² Hemingway, L.³ Hemstreet III, G.P.⁴ Bradlez, E.⁵ Konrad, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.